Pancreatic Cancer Research

ResearcherThe Ohio State UniversityNo recent work listed

I‐Lu Lai

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113139304. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Efficacy of HMJ-38, a new quinazolinone analogue, against the gemcitabine-resistant MIA-PaCa-2 pancreatic cancer cells. Co-author DOI 10.37796/2211-8039.1423↗
  2. Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells. Co-author DOI 10.1093/carcin/bgu124↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mann‐Jen Hour · 1 shared paper, 2023 · strength 0.18
  2. Shih‐Chang Tsai · 1 shared paper, 2023 · strength 0.18
  3. Lawrence A. Shirley · 1 shared paper, 2014 · strength 0.04
  4. Mark Bloomston · 1 shared paper, 2014 · strength 0.04
  5. Tanios Bekaii‐Saab · 1 shared paper, 2014 · strength 0.04
  6. Ching‐Shih Chen · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.